The low anterior resection syndrome in a reference population: prevalence and predictive factors in the Netherlands

被引:35
作者
van Heinsbergen, M. [1 ]
Van der Heijden, J. A. G. [2 ]
Stassen, L. P. [3 ]
Melenhorst, J. [3 ]
de Witte, E. [4 ]
Belgers, E. H. [4 ]
Maaskant-Braat, A. J. G. [2 ]
Bloemen, J. G. [5 ]
Bouvy, N. D. [3 ]
Janssen-Heijnen, M. L. [6 ,7 ]
Konsten, J. L. [1 ]
机构
[1] VieCuri Med Ctr, Dept Surg, Tegelseweg 210, NL-5912 BL Venlo, Netherlands
[2] Maxima Med Ctr, Dept Surg, Veldhoven, Netherlands
[3] Maastricht Univ, Dept Surg, Med Ctr, Uniklin Aachen, Maastricht, Netherlands
[4] Zuyderland Med Ctr, Dept Surg, Sittard Geleen, Netherlands
[5] Catharina Hosp, Dept Surg, Eindhoven, Netherlands
[6] VieCuri Med Ctr, Dept Clin Epidemiol, Venlo, Netherlands
[7] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Med Ctr, Maastricht, Netherlands
关键词
health-related quality of life; bowel dysfunction; low anterior resection syndrome; normative data; QUALITY-OF-LIFE; RECTAL-CANCER; NEOADJUVANT THERAPY; COLORECTAL-CANCER; BOWEL DYSFUNCTION; VALIDATION; SURVIVORS; RISK;
D O I
10.1111/codi.14790
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim The low anterior resection syndrome (LARS) severely affects quality of life (QoL) after colorectal cancer surgery. There are no data about these complaints and the association with QoL in a reference population. The aim of this study was to assess LARS and the association with QoL in a reference population. Methods Six hundred patients who visited the outpatient clinic because of general or trauma surgical indications were asked to participate in this study. They received an invitation letter containing three validated questionnaires to assess LARS (assessed with the LARS score) and both general [European Organization for the Research and Treatment of Cancer (EORTC) QLQ-C30] and colorectal-specific (EORTC QLQ-CR29) QoL. Results Five hundred and one respondents could be included for the analyses. The median age at inclusion was 68 years and 47.3% were men. Major LARS was observed in 15% of patients (11.4% in men and 18.9% in women, P = 0.021). Women reported more urgency (P = 0.070) and incontinence for both flatus (P < 0.001) and stool (P = 0.063) compared to men. In univariate analyses, women reported major LARS significantly more often than men (OR 1.82; 95% CI 1.10-3.01). Patients with major LARS scored significantly worse in most QoL domains compared to patients with no/minor LARS. Conclusion This is the first study demonstrating major LARS and the association with QoL in a reference population of patients without colorectal cancer. Our data can assist in the interpretation of LARS in past and future research about abdominal complaints after colorectal cancer surgery.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 26 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Predicting the Risk of Bowel-Related Quality-of-Life Impairment After Restorative Resection for Rectal Cancer: A Multicenter Cross-Sectional Study [J].
Battersby, Nick J. ;
Juul, Therese ;
Christensen, Peter ;
Janjua, Ahmed Z. ;
Branagan, Graham ;
Emmertsen, Katrine J. ;
Norton, Christine ;
Hughes, Robert ;
Laurberg, Soren ;
Moran, Brendan J. .
DISEASES OF THE COLON & RECTUM, 2016, 59 (04) :270-280
[3]   Neoadjuvant therapy abolishes the functional benefits of a larger rectal remnant, as measured by magnetic resonance imaging after restorative rectal cancer surgery [J].
Bondeven, P. ;
Emmertsen, K. J. ;
Laurberg, S. ;
Pedersen, B. G. .
EJSO, 2015, 41 (11) :1493-1499
[4]   Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study [J].
Bregendahl, S. ;
Emmertsen, K. J. ;
Lous, J. ;
Laurberg, S. .
COLORECTAL DISEASE, 2013, 15 (09) :1130-1139
[5]   Neorectal hyposensitivity after neoadjuvant therapy for rectal cancer [J].
Bregendahl, Sidse ;
Emmertsen, Katrine Jossing ;
Fassov, Janne ;
Krogh, Klaus ;
Zhao, Jingbo ;
Gregersen, Hans ;
Laurberg, Soren .
RADIOTHERAPY AND ONCOLOGY, 2013, 108 (02) :331-336
[6]   Anterior resection syndrome [J].
Bryant, Catherine L. C. ;
Lunniss, Peter J. ;
Knowles, Charles H. ;
Thaha, Mohamed A. ;
Chan, Christopher L. H. .
LANCET ONCOLOGY, 2012, 13 (09) :E403-E408
[7]   Health-Related Quality of Life Among Long-Term Survivors of Colorectal Cancer: A Population-Based Study [J].
Caravati-Jouvenceaux, Agnes ;
Launoy, Guy ;
Klein, Delphine ;
Henry-Amar, Michel ;
Abeilard, Edwige ;
Danzon, Arlette ;
Pozet, Astrid ;
Velten, Michel ;
Mercier, Mariette .
ONCOLOGIST, 2011, 16 (11) :1626-1636
[8]   Are we undertreating rectal cancer in the elderly? An epidemiologic study [J].
Chang, George J. ;
Skibber, John M. ;
Feig, Barry W. ;
Rodriguez-Bigas, Miguel .
ANNALS OF SURGERY, 2007, 246 (02) :215-221
[9]   Bowel dysfunction after rectal cancer treatment: a study comparing the specialist's versus patient's perspective [J].
Chen, Tina Yen-Ting ;
Emmertsen, Katrine Jossing ;
Laurberg, Soren .
BMJ OPEN, 2014, 4 (01)
[10]   A hyperactive postprandial response in the neorectum - the clue to low anterior resection syndrome after total mesorectal excision surgery? [J].
Emmertsen, K. J. ;
Bregendahl, S. ;
Fassov, J. ;
Krogh, K. ;
Laurberg, S. .
COLORECTAL DISEASE, 2013, 15 (10) :e599-e606